tiprankstipranks
DocGo (DCGO)
NASDAQ:DCGO
US Market

DocGo Stock Price & Analysis

51 Followers

DCGO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$4.96 - $11.86
Previous Close$9.92
Volume350.73K
Average Volume (3M)654.10K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$32.42M
Total Debt (Recent Filing)$13.14M
P/E Ratio0.4
Beta1.01
Next EarningsNov 16, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)26.67
Shares Outstanding101,025,267
R-Squared0.15
Standard Deviation0.14
10 Day Avg. Volume687,710
30 Day Avg. Volume654,098
P/B Ratio4.40
P/S Ratio2.87
P/CF Ratio34.00
P/FCF Ratio66.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside24.88% Upside
Rating ConsensusModerate Buy
Alpha0.00577
Number of Analyst Covering2


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

DCGO FAQ

What was DocGo’s price range in the past 12 months?
DocGo lowest stock price was $4.96 and its highest was $11.86 in the past 12 months.
    What is DocGo’s market cap?
    Currently, no data Available
    When is DocGo’s upcoming earnings report date?
    DocGo’s upcoming earnings report date is Nov 16, 2022 which is in 43 days.
      How were DocGo’s earnings last quarter?
      DocGo released its earnings results on Aug 08, 2022. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.037 by $0.073.
        Is DocGo overvalued?
        According to Wall Street analysts DocGo’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does DocGo pay dividends?
          DocGo does not currently pay dividends.
          What is DocGo’s EPS estimate?
          DocGo’s EPS estimate is $0.05.
            How many shares outstanding does DocGo have?
            DocGo has 101,025,270 shares outstanding.
              What happened to DocGo’s price movement after its last earnings report?
              DocGo reported an EPS of $0.11 in its last earnings report, beating expectations of $0.037. Following the earnings report the stock price went up 3.539%.
                Which hedge fund is a major shareholder of DocGo?
                Among the largest hedge funds holding DocGo’s share is Moore Capital Management LP. It holds DocGo’s shares valued at 4M.

                  ---

                  DocGo Stock Analysis

                  Smart ScoreNeutral
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10
                  7
                  The DocGo stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  DocGo

                  Motion Acquisition Corp is a blank check company.

                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  CVS Health
                  Cigna
                  Quest Diagnostics
                  R1 RCM
                  Laboratory

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis